Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients.
about
Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancersOral human papillomavirus is common in individuals with Fanconi anemiaChimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)Immunogenicity of Human Papillomavirus Recombinant Vaccine in Children with CKDImmunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review.Immunization after kidney transplantation-what is necessary and what is safe?Beyond passive immunization: toward a nanoparticle-based IL-17 vaccine as first in class of future immune treatments.Vaccine-preventable infection morbidity of patients with chronic kidney disease and cocoon vaccination strategies.Prophylactic HPV vaccination: past, present, and future.Literature-based immunization recommendations for patients requiring immunosuppressive medications for autoimmune bullous dermatoses.Human Papillomavirus in Kidney Transplant Recipients.Cervical human papillomavirus infection in the early postoperative period after liver transplantation: Prevalence, risk factors, and concordance with anal infections.Reactivation of Latent HPV Infections After Renal Transplantation.Cervicovaginal HPV infection in female renal transplant recipients: an observational, self-sampling based, cohort study.Immunogenicity of a prophylactic quadrivalent human papillomavirus L1 virus-like particle vaccine in male and female adolescent transplant recipients.Renal association clinical practice guideline in post-operative care in the kidney transplant recipientHPV vaccination of immunocompromised hosts.Liver transplant recipients have a higher prevalence of anal squamous intraepithelial lesions.Dermatological conditions seen in renal transplant recipients in a Singapore tertiary hospital
P2860
Q28088322-53F0132D-18DF-46FB-A31D-570849516F21Q35633774-58595705-CA4D-4AB4-B5D9-20AE5EB0B798Q36240497-91162918-03B6-412C-A92F-9BF1679B96A7Q36874555-FC13D537-85A3-4220-AAAB-1BD37DEEF233Q37320197-A7CA2323-0391-4EB4-946C-0C3C491E0716Q38235003-08E6FEE3-CF0B-4D85-BD37-C802E522B12EQ38467270-4E34B34B-9AAF-4D50-A612-C9CA9D170294Q38569825-4D7BF05F-5EFB-4D5F-816A-F93A34671683Q38597567-9FB09AE5-5D3F-42FD-8300-54467B2C43A1Q38681669-F1668D20-80FA-458C-AC9E-B86BAFF51C7EQ38988685-BD2F09D4-C417-4CF1-87CA-C8A20B815F36Q39091662-0A5BBB04-5357-4205-A2D3-BAB560D0CCE3Q40397729-F95533BB-2E06-40A1-A1C6-1C3DC008969EQ41444452-35AB0F61-E388-4C49-A414-A47B3332F4A0Q42239771-FDD899C3-3E28-46E7-8FD1-993FC0BC0233Q42343473-2E90E938-299A-4D4D-B24C-A318553B0CD2Q46355059-7AE05837-B57B-4E28-B702-B37F0F797818Q51768810-961A4BB5-1454-4B7B-A995-18DA0275912CQ58602498-47A87FF2-5560-4A58-B146-12BE5FCAD9A8
P2860
Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Immunogenicity of quadrivalent ...... n organ transplant recipients.
@ast
Immunogenicity of quadrivalent ...... n organ transplant recipients.
@en
type
label
Immunogenicity of quadrivalent ...... n organ transplant recipients.
@ast
Immunogenicity of quadrivalent ...... n organ transplant recipients.
@en
prefLabel
Immunogenicity of quadrivalent ...... n organ transplant recipients.
@ast
Immunogenicity of quadrivalent ...... n organ transplant recipients.
@en
P2093
P2860
P356
P1476
Immunogenicity of quadrivalent ...... n organ transplant recipients.
@en
P2093
P2860
P304
P356
10.1111/AJT.12329
P407
P577
2013-07-09T00:00:00Z